免疫环境因子IEF在EGFR-TKIs治疗的EGFR突变阳性晚期非小细胞肺癌中预后价值研究The Predictive Value of Immune Environment Factors (IEF) for the Prognosis of EGFR Mutations Positive Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs)
杨 雪, 刘根利, 李 玲, 吴大鹏, 王笑荷, 陶凤英, 袁胜利 国家自然科学基金支持
临床医学进展Vol.11 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.118519, August 20 2021
Ib~IIb期非小细胞肺癌术后生活质量观察Observation of Quality of Life for Ib~IIb Stage Non-Small Cell Lung Cancer after Complete Resection
欧阳怡然, 李和根 科研立项经费支持
临床医学进展Vol.13 No.6, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1361380, June 25 2023
一代TKIs治疗不可切除的EGFR突变阳性NSCLC患者的研究Study on First-Generation TKIs in the Treatment of Patients with Unresectable EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
王子繁, 代成成, 乔中石, 马学真
临床医学进展Vol.12 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.122111, February 8 2022
吉非替尼治疗一例肺腺癌脑转移患者疗效分析Analysis of the Efficacy of Gefitinib in the Treatment of Brain Metastases of Lung Adenocarcinoma
白引苗, 陈 衍, 吴剑维, 孔胜男, 李新涛, 张红梅 国家科技经费支持
亚洲肿瘤科病例研究Vol.7 No.3, 全文下载: PDF DOI:10.12677/ACRPO.2018.73004, July 16 2018
EGFR突变肺腺癌耐药后双靶治疗致急性间质性肺炎1例并文献复习Acute Interstitial Pneumonia Caused by Dual-Target Therapy in Resistant EGFR-Mutated Lung Adenocarcinoma: A Case Report and Literature Review
张 彩, 肖玉婷, 毕焕焕, 易冰倩, 周银雪, 李鑫慧, 杨子艺, 徐博文, 余 西, 孙家兴 科研立项经费支持
临床医学进展Vol.15 No.4, 全文下载: PDF XML DOI:10.12677/acm.2025.1541206, April 22 2025
中医药治疗非小细胞肺癌EGFR-TKIs相关性腹泻的研究进展Research Progress of Traditional Chinese Medicine in Treating EGFR-TKIs Related Diarrhea in Non-Small Cell Lung Cancer
李锐平
中医学Vol.12 No.11, 全文下载: PDF HTML XML DOI:10.12677/TCM.2023.1211494, November 27 2023